CTRI/2013/11/004160已完成2 期
A randomized, parallel group, active controlled trial to evaluate curcumin as a pulpotomy medicament in deciduous teeth
Maratha Mandals NGH institute of Dental Sciences Research Centre Belgaum0 个研究点目标入组 100 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Primary molars with vital carious pulp exposures that bleed upon entering the pulp chambers.
- •2. Teeth that could be restored with stainless steel crowns.
排除标准
- •1. Presence of spontaneous pain, pain on percussion, history of swelling or sinus tracts.
- •2. Radiographic signs of internal / pathological external resorption, widened PDL spaces and furcation radiolucency.
- •3. More than one third physiologic root resorption.
研究者
相似试验
进行中（未招募）
不适用
A randomized, active controlled, parallel group, multi-center, two phase, open label study comparing safety and immunogenicity of Insugen R and Insugen N with Actrapid and Insulatard in patients with type 1 diabetes melllitus. - NADiabetes mellitus type 1MedDRA version: 12.1Level: LLTClassification code 10045228Term: Type I diabetes mellitusEUCTR2010-018354-12-HUBiocon S.A.286
已完成
3 期
A clinical trial to study safety and efficacy of two drugs Insugen® R and Insugen® N with Actrapid® and Insulatard® in Patients with Type 1 Diabetes Mellitus.CTRI/2010/091/000627Biocon SA286
Unknown
3 期
A clinical trial to study safety and efficacy of two drugs Insugen® R and Insugen® N with Actrapid® and Insulatard® in Patients with Type 1 Diabetes Mellitus.CTRI/2009/091/000098Biocon S.A. Fid Borruat Sarl, Sous Maichereux 20 Case postale 2027 CH-2800, Delemont, Switzerland274
进行中（未招募）
不适用
A Randomized, Active Controlled, Parallel Group, Multicentre, Two-Phase, Open-Label Study Comparing the Safety and Immunogenicity of Insugen R and Insugen N with Actrapid and Insulatard in Patients with Type 1 Diabetes MellitusType 1 Diabetes mellitusEUCTR2010-018354-12-DEBiocon S.A.286
进行中（未招募）
不适用
A Randomized, Active Controlled, Parallel Group, Multicentre, Two-Phase, Open-Label Study Comparing the Safety and Immunogenicity of Insugen R and Insugen N with Actrapid and Insulatard in Patients with Type 1 Diabetes Mellitus - NDDiabetes Mellitus Type 1MedDRA version: 9.1Level: LLTClassification code 10045228EUCTR2010-018354-12-ITBIOCON S A286